IDH3B

isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta, the group of Isocitrate dehydrogenases

Basic information

Region (hg38): 20:2658393-2664219

Links

ENSG00000101365NCBI:3420OMIM:604526HGNC:5385Uniprot:O43837AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • retinitis pigmentosa (Supportive), mode of inheritance: AD
  • retinitis pigmentosa 46 (Strong), mode of inheritance: AR
  • retinitis pigmentosa 46 (Strong), mode of inheritance: AR
  • IDH3B-related retinopathy (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Retinitis pigmentosa 46ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic18806796

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IDH3B gene.

  • not_provided (277 variants)
  • not_specified (44 variants)
  • Retinitis_pigmentosa (30 variants)
  • Retinal_dystrophy (19 variants)
  • Retinitis_pigmentosa_46 (14 variants)
  • IDH3B-related_disorder (4 variants)
  • Optic_atrophy (2 variants)
  • Retinitis_Pigmentosa,_Recessive (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IDH3B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006899.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
66
clinvar
2
clinvar
73
missense
136
clinvar
2
clinvar
138
nonsense
3
clinvar
4
clinvar
1
clinvar
8
start loss
1
1
frameshift
3
clinvar
4
clinvar
4
clinvar
11
splice donor/acceptor (+/-2bp)
8
clinvar
4
clinvar
12
Total 6 17 150 68 2

Highest pathogenic variant AF is 0.000039030845

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IDH3Bprotein_codingprotein_codingENST00000380843 125825
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.99e-110.1551256820661257480.000262
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4192002170.9200.00001292523
Missense in Polyphen7395.9870.760521149
Synonymous-0.4598983.71.060.00000508758
Loss of Function0.6281821.10.8520.00000117244

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002970.000297
Ashkenazi Jewish0.0001980.000198
East Asian0.0002170.000217
Finnish0.0002310.000231
European (Non-Finnish)0.0003260.000325
Middle Eastern0.0002170.000217
South Asian0.0001640.000163
Other0.0008150.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a structural role to facilitate the assembly and ensure the full activity of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers. {ECO:0000269|PubMed:28139779}.;
Disease
DISEASE: Retinitis pigmentosa 46 (RP46) [MIM:612572]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:18806796}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Citrate cycle (TCA cycle) - Homo sapiens (human);Warburg Effect;The oncogenic action of Succinate;The oncogenic action of Fumarate;Pyruvate dehydrogenase deficiency (E3);Pyruvate dehydrogenase deficiency (E2);2-ketoglutarate dehydrogenase complex deficiency;Mitochondrial complex II deficiency;Fumarase deficiency;Congenital lactic acidosis;Citric Acid Cycle;Glutaminolysis and Cancer;The oncogenic action of 2-hydroxyglutarate;The oncogenic action of L-2-hydroxyglutarate in Hydroxygluaricaciduria;The oncogenic action of D-2-hydroxyglutarate in Hydroxygluaricaciduria ;TCA Cycle;Citrate cycle;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TCA cycle;TCA cycle;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle (Consensus)

Recessive Scores

pRec
0.236

Intolerance Scores

loftool
0.902
rvis_EVS
-0.4
rvis_percentile_EVS
26.73

Haploinsufficiency Scores

pHI
0.379
hipred
N
hipred_score
0.439
ghis
0.589

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.842

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Idh3b
Phenotype

Gene ontology

Biological process
tricarboxylic acid cycle;isocitrate metabolic process;electron transport chain
Cellular component
nucleus;mitochondrion;mitochondrial matrix
Molecular function
magnesium ion binding;isocitrate dehydrogenase (NAD+) activity;electron transfer activity;NAD binding